The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, WAVE Life Sciences's share price is $4.66.
WAVE Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.06. Hence, WAVE Life Sciences's PS Ratio for today is 4.40.
The historical rank and industry rank for WAVE Life Sciences's PS Ratio or its related term are showing as below:
WVE'
s PS Ratio Range Over the Past 10 Years
Min: 1.47 Med: 47.57 Max: 3375
Current: 4.4
During the past 11 years, WAVE Life Sciences's highest PS Ratio was 3375.00. The lowest was 1.47. And the median was 47.57.
WVE's PS Ratio is ranked better than 69.25% of 992
companies
in the Biotechnology industry
Industry Median: 8.85
vs WVE: 4.40
WAVE Life Sciences Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of WAVE Life Sciences was 2221.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 27.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -7.50% per year.
During the past 11 years, WAVE Life Sciences's highest 3-Year average Revenue per Share Growth Rate was 228.90% per year. The lowest was -54.00% per year. And the median was 39.70% per year.
Back to Basics: PS Ratio
WAVE Life Sciences PS Ratio Historical Data
The historical data trend for WAVE Life Sciences's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of WAVE Life Sciences's PS Ratio
For the Biotechnology subindustry, WAVE Life Sciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WAVE Life Sciences's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, WAVE Life Sciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where WAVE Life Sciences's PS Ratio falls into.
WAVE Life Sciences PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
WAVE Life Sciences's Share Price of today is $4.66. WAVE Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
WAVE Life Sciences PS Ratio Related Terms
Thank you for viewing the detailed overview of WAVE Life Sciences's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
WAVE Life Sciences (WAVE Life Sciences) Business Description
WAVE Life Sciences Ltd is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WVE has been successfully added to your 